Does Dr. JOSEPH ARDITO have financial conflicts of interest?

Dr. JOSEPH ARDITO (M.D.) has received a total of $170 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $170 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JOSEPH ARDITO?

According to CMS Open Payments data, Dr. JOSEPH ARDITO received funding from GLAXOSMITHKLINE ($60), REGENERON HEALTHCARE SOLUTIONS ($34), and GENZYME CORPORATION ($25).

Does Dr. JOSEPH ARDITO receive research grants or speaking fees?

Dr. JOSEPH ARDITO has received $170 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JOSEPH ARDITO

M.D.Real-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: PAOLI, PA 19301

NPI Number: 1124137369

LIFETIME INDUSTRY VALUE

$170

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ARDITO is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in PAOLI, PA.

Between 2021 and 2024, Dr. ARDITO had an overall industry promotional and research financial footprint of $170 as recorded in the federal CMS Open Payments database.

$170 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARDITO's primary funding source is GLAXOSMITHKLINE, which accounts for $60 (representing 35.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$60

35.5%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$34

20.2%

GENZYME CORPORATION

Rank 3

$25

14.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.